News – Page 26 – Endpoints News

Candel to focus on non-squamous lung cancer following new survival data

2 months ago

Galatea Bio gets $25M to map genetic diversity of 10 million people, help pharma create new medicines

2 months ago

Aurion CEO is out as Alcon takes majority stake in cell therapy startup

2 months ago

FDA approves first drug for Prader-Willi syndrome, to tamp down insatiable hunger symptoms

2 months ago

FDA critiques Taiho Oncology's 'misleading' promotional website for bile duct cancer drug

2 months ago

Exelixis’ primary cancer drug wins FDA approval for neuroendocrine tumors

2 months ago

Small biotech joins list of health companies taking a trip to Trump's Mar-a-Lago

2 months ago

J&J touts new survival data pitting lung cancer combo against AstraZeneca's rival

2 months ago

Wave strengthens case for accelerated approval, with more positive Duchenne data

2 months ago

ElevateBio trims workforce by 17%

2 months ago

Humacyte to raise $50M; Acrivon to focus on prexasertib in endometrial cancer

2 months ago

The Endpoints Slack interview: Duke’s Pranam Chatterjee unpacks AI bio’s pretty picture fallacy

2 months ago

Epicrispr raises $68M, will start clinical trial of epigenetic editing for FSHD

2 months ago

Trump tariffs would increase costs for almost every biopharma company, survey claims

2 months ago

Senate confirms Makary as FDA chief with agency cuts, return-to-office in force

2 months ago

Covid contrarian Bhattacharya is confirmed as NIH chief, taking over at a fraught moment for federal research

2 months ago

Lyndra Therapeutics to wind down amid funding hurdles for long-acting drug technology

2 months ago

Eisai cuts Leqembi 2027 sales forecast by half but expects 'continued growth'

2 months ago

Senate committee backs Dr. Oz's nomination to lead CMS

2 months ago

Revvity secures $37.8M contract to help screen UK newborns for rare diseases

2 months ago

DOGE pulls three FDA lease closures from 'Wall of Receipts,' including St. Louis quality lab

2 months ago

Illumina adds activist investor to board, taps former FDA head as chair

2 months ago

Calculating healthcare's real costs

2 months ago

Axsome reports Phase 3 win for Sunosi in adults with ADHD, with a high-dose caveat

2 months ago

First page Previous page 23 24 252627 28 29 Next page Last page